Draeger J
Univ.-Augenklinik, Hamburg.
Klin Monbl Augenheilkd. 1993 Jan;202(1):2-7. doi: 10.1055/s-2008-1045551.
There is no doubt that an elevation of intraocular pressure (IOP) precedes any morphological or functional glaucomatous damage for years, if not decades. Surprisingly, in the present glaucoma literature methods for a quantification of such a damage are prevailing. There might be two reasons for this: The question of tonometry is supposed to be perfectly and definitely solved or tonometry as the most significant diagnostic tool for an early diagnosis of glaucoma has been lost out of sight. Two aspects shall be discussed in the following: Firstly, we want to deal with an improved glaucoma management especially in the early phase of the disease. The question is when and how often should tonometry be performed to detect the typically greater diurnal fluctuations of IOP in glaucoma. This has already been pointed out in particular by Sampaolesi and Hager. Secondly, the technique of the most appropriate tonometer for this purpose is outlined. Important aspects are the accuracy of the instrument according to the standard set by the Goldmann applanatation tonometer as well as safety and easy handling. Like in other branches of medicine where the patient is more and more involved in his own disease control (eg self-measurement of blood pressure in patients with arterial hypertension), self-tonometry is likely to become a revolutionary step towards an improved management and follow-up of glaucoma. These are the objectives we should concentrate on. Technical solutions, clinical applications and experiences are demonstrated.
毫无疑问,眼内压(IOP)升高在数年甚至数十年前就先于任何形态学或功能性青光眼损害出现。令人惊讶的是,在当前的青光眼文献中,量化这种损害的方法占主导地位。可能有两个原因:眼压测量问题被认为已得到完美且明确的解决,或者眼压测量作为青光眼早期诊断最重要的诊断工具已被忽视。以下将讨论两个方面:首先,我们想探讨改善青光眼管理,尤其是在疾病早期。问题是何时以及多久应进行眼压测量以检测青光眼患者中典型的较大昼夜眼压波动。这一点尤其已被桑帕奥莱西和哈格指出。其次,概述了为此目的最合适眼压计的技术。重要方面包括根据戈德曼压平眼压计设定的标准衡量仪器的准确性以及安全性和易于操作。就像在医学的其他分支中患者越来越多地参与自身疾病控制(例如动脉高血压患者自测血压)一样,自我眼压测量可能成为改善青光眼管理和随访的革命性一步。这些是我们应关注的目标。文中展示了技术解决方案、临床应用及经验。